WEBINAR: The one test every cancer patient should know

Register to Attend Online (Free)

You'll be able to join live while we record.
You are all registered!

You will get an email with all the information you'll need to connect.

We look forward to seeing you!
Oops! Something went wrong while submitting the form.

Just over five years ago, the FDA approved the first comprehensive NextGeneration Sequencing tests. 

This test takes a pieces of a person’s actual tumor and analyzes the genetic mutations. When we talk of personalized treatment, this is it. 

We believe all high-risk cancer patients should get NextGeneration tumor sequencing.

In this webinar, we discuss what makes a patient high-risk, what the test does for patients, and how to get it.

You may know the test by other names:

- Genetic Analysis

- Molecular Profiling

- Tumor Sequencing

- Biomarker Testing

- Genomic Testing

- Next Generation (NextGen) Sequencing

Essentially they are all the same in that they look at the DNA makeup of a patient's cancer. And for nearly every patient, this is different and can guide them to the best cancer care possible.


0:00 Introduction

0:37 What is the one test that every single cancer patient should know?

4:27 What are gene mutations like BRAC?

6:04 What makes it NextGen sequencing?

8:01 Who should get NextGen sequencing?

11:53 How do you get NextGen sequencing done and get the report?

14:10 How Does this affect treatment decisions?

15:34 How else is tumor sequencing helpful to cancer patients?

18:04 Why aren’t more cancer patients getting this test done?

19:23 When and how do you ask your oncologist about this?

23:47 What to do if no tumor tissue is available (circulating tumor DNA test)

25:17 What to do if your oncologist won’t order the test?

26:28 What test is best (any that test as much as possible)?

27:55 Why my oncologist tells me that the report won’t change my treatment?

29:09 Matching to clinical trials from NextGen sequencing.